Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 in Sjögren's Syndrome
NCT05005806Phase 3Completed
- Sponsor
- Hawler Medical University
- Start
- Sep 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid in Sjögren's syndrome, sponsored by Hawler Medical University. Started Sep 2021; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT05005806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005806.